MPM BIO IV NVS STRATEGIC FUND

MPM Bio IV NVS Strategic Fund is focused on investments in companies based in the biotechnology industry.

#Financial #More

MPM BIO IV NVS STRATEGIC FUND

Status:
Active


Investments List

Date Company Article Money raised
2013-04-25 Radius Health MPM Bio IV NVS Strategic Fund investment in Private Equity Round - Radius Health 43 M USD
2009-05-28 Proteon Therapeutics MPM Bio IV NVS Strategic Fund investment in Series B - Proteon Therapeutics 50 M USD
2008-11-20 Radius Health MPM Bio IV NVS Strategic Fund investment in Series C - Radius Health 15 M USD
2007-09-17 Radius Health MPM Bio IV NVS Strategic Fund investment in Series C - Radius Health 10 M USD
2005-05-05 AVEO Oncology MPM Bio IV NVS Strategic Fund investment in Series C - AVEO Oncology 5 M USD

More informations about "MPM Bio IV NVS Strategic Fund"

MPM Bio IV NVS Strategic Fund - Crunchbase

MPM Bio IV NVS Strategic Fund is focused on investments in companies based in the biotechnology industry. Cambridge , Massachusetts , United States Venture CapitalSee details»

MPM Bio IV NVS Strategic Fund: Performance | PitchBook

Nov 15, 2006 · MPM Bio IV NVS Strategic Fund is a venture capital fund managed by MPM Capital. The fund is located in Boston, Massachusetts. The fund targeted to invest in the life …See details»

MPM Bio IV NVS Strategic Fund - Crunchbase

MPM Bio IV NVS Strategic Fund is focused on investments in companies based in the biotechnology industry.See details»

MPM Bio IV NVS Strategic Fund LP | AUM 13F

Public filings of MPM Bio IV NVS Strategic Fund LP raised by MPM Asset Management LLC. Direct links to the EDGAR source material.See details»

MPM Bio 2014 NVS Strategic Fund: Performance | PitchBook

Mar 18, 2015 · Information on investments, limited partners, investment strategy, and returns for MPM Bio 2014 NVS Strategic Fund. Use the PitchBook Platform to explore the full profile.See details»

Radius Announces Closing of $91 Million Financing to Advance …

May 24, 2011 · Five new investors, including BB Biotech AG, Brookside Capital, Saints Capital, Nordic Bioscience (“Nordic”), and Ipsen Pharma SAS (“Ipsen”) joined existing investors MPM …See details»

MPM BIO IV NVS STRATEGIC FUND LP - WhaleWisdom.com

Detailed Profile of MPM BIO IV NVS STRATEGIC FUND LP portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.See details»

MPM Bio IV NVS Strategic Fund - Updates, News, Events

Sep 17, 2021 · MPM Bio IV NVS Strategic Fund is focused on investments in companies based in the biotechnology industry.See details»

Elixir Pharmaceuticals Signs Option Agreement with a Major ...

May 20, 2009 · Elixir also announced it has completed a $12 million equity financing, led by MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund L.P. In addition to MPM, the financing …See details»

MPM Bio V NVS Strategic Fund: Performance | PitchBook

Jun 13, 2014 · MPM Bio V NVS Strategic Fund is a venture capital fund managed by MPM Capital. The fund is located in Boston, Massachusetts. The fund invests in the life science, …See details»

PRESS RELEASE: Radius Grants Major Pharmaceutical Company …

Sep 17, 2007 · "This major commitment by the MPM Bio IV NVS Strategic Fund L.P. reflects our belief in the potential of BA058 to address important unmet needs for osteoporosis patients in …See details»

Chiasma Grants Option to License Transient Permeability Enhancer …

Jan 19, 2010 · In a separate but related agreement, the MPM Bio IV NVS Strategic Fund L.P. made an equity investment in Chiasma. The two companies have initiated a feasibility program …See details»

Novartis options Proteon Therapeutics for $550M

Mar 5, 2009 · The Series B financing includes new investors, the MPM Bio IV NVS Strategic Fund L.P. and the Vectis Healthcare & Life Sciences Fund, along with existing investors TVM …See details»

Series C - Radius Health - 2008-11-20 - Crunchbase

Nov 20, 2008 · MPM Bio IV NVS Strategic Fund MPM Bio IV NVS Strategic Fund is focused on investments in companies based in the biotechnology industry. Fierce Biotech — Radius …See details»

Peptimmune, Inc. Grants Major Pharmaceutical Company Exclusive …

Jan 15, 2009 · In a separate but related agreement, the MPM Bio IV NVS Strategic Fund L.P. made an equity investment in Peptimmune. In the event that Novartis exercises the option to …See details»

Radius glows with $43m - globalventuring.com

Apr 26, 2013 · Novartis’s pharmaceutical business unit invested in Radius’ latest round through its joint programme with venture capital firm MPM Capital’s MPM Bio IV NVS Strategic Fund. The …See details»

Chiasma Grants Option To License Transient Permeability …

Jan 21, 2010 · In a separate but related agreement, the MPM Bio IV NVS Strategic Fund L.P. made an equity investment in Chiasma. The two companies have initiated a feasibility program …See details»

Novartis options osteoporosis drug | Fierce Biotech

Sep 17, 2007 · Novartis inked a deal to option a Phase II drug for osteoporosis from Radius Health. The deal is worth more than $500 million in potential milestone payments and Novartis' …See details»

Proteon Therapeutics Completes $38M Equity Financing ... - Fierce …

WALTHAM, Mass., March 5 /PRNewswire/ -- Proteon Therapeutics, Inc., announced today that it has successfully completed a $38 million Series B equity financing, led by MPM Capital on …See details»

Radius Health Completes $43 Million Financing to ... - Fierce Biotech

Apr 25, 2013 · The financing was led by F2 Biosciences III, L.P., with participation from existing investors, Biotech Growth N.V., MPM Capital, Brookside Capital, MPM Bio IV NVS Strategic …See details»